Hemangiol

Hemangiol (Propranolol) is a prescription medication used to treat infantile hemangiomas, which are benign vascular tumors that develop in infants. It helps shrink the hemangioma and reduce complications such as ulceration, bleeding, or breathing difficulties. Hemangiol is typically prescribed for infants with large or problematic hemangiomas that interfere with normal function.

Most infants show visible improvement within a few weeks of starting Hemangiol. However, complete treatment can take several months, and the medication is often continued for up to six months or longer to ensure complete regression of the hemangioma. Parents should closely monitor their child’s response to treatment and attend follow-up appointments as scheduled.

Hemangiol is provided as an oral liquid, typically twice a day. It should be administered during or immediately after feeding to reduce the risk of low blood sugar. The dose is calculated based on the infant’s weight and is adjusted as they grow. Always use the provided measuring device to ensure accurate dosing.

Give it as soon as you remember if a dose is missed unless it is close to the next scheduled dose. Do not double up on doses. If multiple doses are missed, consult your healthcare provider for guidance on safely resuming treatment.

While most infants tolerate Hemangiol well, it can cause serious side effects such as low blood sugar (especially if taken on an empty stomach), slow heart rate, low blood pressure, or breathing difficulties. If your child experiences extreme drowsiness, pale skin, wheezing, or difficulty breathing, seek immediate medical attention.